CA3234324A1 - Peptide - Google Patents
Peptide Download PDFInfo
- Publication number
- CA3234324A1 CA3234324A1 CA3234324A CA3234324A CA3234324A1 CA 3234324 A1 CA3234324 A1 CA 3234324A1 CA 3234324 A CA3234324 A CA 3234324A CA 3234324 A CA3234324 A CA 3234324A CA 3234324 A1 CA3234324 A1 CA 3234324A1
- Authority
- CA
- Canada
- Prior art keywords
- amino acid
- peptide
- tgf
- peptide according
- nall
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021-161353 | 2021-09-30 | ||
| JP2021161353 | 2021-09-30 | ||
| PCT/JP2022/036850 WO2023054712A1 (ja) | 2021-09-30 | 2022-09-30 | ペプチド |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3234324A1 true CA3234324A1 (en) | 2023-04-06 |
Family
ID=85780814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3234324A Pending CA3234324A1 (en) | 2021-09-30 | 2022-09-30 | Peptide |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20250034212A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4410816A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JPWO2023054712A1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240082377A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118103387A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022355276A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3234324A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL311773A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202334179A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023054712A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024347940A1 (en) * | 2023-09-29 | 2026-04-30 | Peptidream Inc. | Peptide |
| WO2025100520A1 (ja) * | 2023-11-10 | 2025-05-15 | ペプチドリーム株式会社 | ペプチド、ペプチド複合体、医薬組成物、細胞培養用組成物、及び医療用、診断用又は研究用に用いられる組成物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5240912A (en) * | 1983-05-09 | 1993-08-31 | Todaro George J | Transforming growth factor (TGF) peptides |
| US5525491A (en) | 1991-02-27 | 1996-06-11 | Creative Biomolecules, Inc. | Serine-rich peptide linkers |
| PT1263464E (pt) * | 2000-03-09 | 2012-12-17 | Genzyme Corp | Utilização de anticorpos anti-tgf-beta antagonistas para tratar ou para prevenir a perda da função renal |
| SI1724284T1 (sl) | 2000-12-07 | 2009-12-31 | Lilly Co Eli | Glp-1 fuzijski proteini |
| CA2484994C (en) * | 2002-04-29 | 2016-06-14 | St. Louis University | Peptide antagonists of tgf-beta family members and therapeutic uses thereof |
| EP1964916B1 (en) | 2005-12-06 | 2012-08-01 | The University of Tokyo | Multi-purpose acylation catalayst and use thereof |
| EP2419116A1 (en) * | 2009-04-13 | 2012-02-22 | North Western University | Novel peptide-based scaffolds for cartilage regeneration and methods for their use |
| CA2809568C (en) | 2010-09-01 | 2019-06-11 | Genzyme Corporation | Treatment of myocardial infarction using tgf - beta antagonists |
| PL3089971T3 (pl) | 2014-01-01 | 2021-01-25 | Medivation Technologies Llc | Związki i sposoby ich zastosowania |
| WO2017024407A1 (en) * | 2015-08-11 | 2017-02-16 | The Royal Institution For The Advancement Of Learning/Mcgill University | Peptidic tgf-beta antagonists |
| KR102631542B1 (ko) * | 2018-03-14 | 2024-02-01 | 서울대학교산학협력단 | 염증 감소능 및 줄기세포로부터 연골세포로의 분화 촉진능을 가지는 이중 기능성 펩타이드 및 이의 용도 |
| JP6952747B2 (ja) | 2018-09-18 | 2021-10-20 | ファイザー・インク | がん処置のためのTGFβ阻害剤およびCDK阻害剤の組合せ |
| EP4410958A4 (en) * | 2021-09-30 | 2025-11-12 | Jsr Corp | PROCESS FOR THE PRODUCTION OF ORGANOIDS, CULTURE MEDIUM FOR THE PRODUCTION OF ORGANOIDS, ORGANOID AND PROCESS FOR EVALUATING TEST SUBSTANCE |
-
2022
- 2022-09-30 AU AU2022355276A patent/AU2022355276A1/en active Pending
- 2022-09-30 WO PCT/JP2022/036850 patent/WO2023054712A1/ja not_active Ceased
- 2022-09-30 KR KR1020247013802A patent/KR20240082377A/ko active Pending
- 2022-09-30 IL IL311773A patent/IL311773A/en unknown
- 2022-09-30 EP EP22876574.9A patent/EP4410816A4/en active Pending
- 2022-09-30 US US18/697,134 patent/US20250034212A1/en active Pending
- 2022-09-30 CA CA3234324A patent/CA3234324A1/en active Pending
- 2022-09-30 TW TW111137268A patent/TW202334179A/zh unknown
- 2022-09-30 JP JP2023551926A patent/JPWO2023054712A1/ja active Pending
- 2022-09-30 CN CN202280066544.0A patent/CN118103387A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW202334179A (zh) | 2023-09-01 |
| AU2022355276A1 (en) | 2024-05-16 |
| JPWO2023054712A1 (cg-RX-API-DMAC7.html) | 2023-04-06 |
| WO2023054712A1 (ja) | 2023-04-06 |
| IL311773A (en) | 2024-05-01 |
| CN118103387A (zh) | 2024-05-28 |
| EP4410816A4 (en) | 2025-11-19 |
| EP4410816A1 (en) | 2024-08-07 |
| US20250034212A1 (en) | 2025-01-30 |
| KR20240082377A (ko) | 2024-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2024200512B2 (en) | Stabilized peptide-mediated targeted protein degradation | |
| WO2015030014A1 (ja) | 大環状ペプチド、その製造方法、及び大環状ペプチドライブラリを用いるスクリーニング方法 | |
| CN115151556A (zh) | 人转铁蛋白受体结合肽 | |
| EP4410816A1 (en) | Peptide | |
| EP3210995B1 (en) | Hemagglutinin-binding peptide | |
| JP7854211B2 (ja) | ヘマグルチニン結合ペプチド | |
| CA3228449A1 (en) | Human transferrin receptor binding peptide | |
| US20250282820A1 (en) | Peptide complex having trkb binding activity | |
| TW202434613A (zh) | 人類運鐵蛋白受體結合肽 | |
| AU2024347940A1 (en) | Peptide | |
| HK40105341A (en) | Human transferrin receptor–binding peptide | |
| CA3282856A1 (en) | Humantransferrin receptor-binding peptide | |
| JP2024523280A (ja) | Ghr結合ペプチドおよびそれを含む組成物 | |
| HK40105891A (en) | Human transferrin receptor-binding antibody-peptide conjugate | |
| AU2024331192A1 (en) | Peptide complex having vegfr -2 agonist activity | |
| Wen | Development and Application of Cell Penetrating Beta-Hairpin and Alpha-Helical Peptides | |
| HK40057758B (zh) | 血球凝集素结合肽 | |
| HK40057758A (en) | Hemagglutinin-binding peptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A00 | Application filed |
Free format text: ST27 STATUS EVENT CODE: A-1-1-A10-A00-A102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: COMPLIANCE REQUIREMENTS DETERMINED MET Effective date: 20240704 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250728 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250728 |